Abstract
Classically, a transient ischemic attack (TIA) has been defined as an acute episode of neurologic symptoms lasting less than 24 hours attributed to focal ischemia in a vascular distribution of the brain or retina. Stroke and TIA share similar risk factors, evaluation, and secondary prevention. However, evaluation of patients with TIA has traditionally lacked the same urgency that has been directed to acute stroke, probably because patients with TIA are at baseline neurologically when the diagnosis is made. Recently, several studies have found a high risk of stroke shortly after TIA. Furthermore, recent evidence suggests that early recovery from ischemia actually is associated with greater instability. Identifying patients with the highest risk of recurrent ischemic events for urgent evaluation and intervention is key in secondary stroke prevention. This article reviews the current literature on new concepts about TIA, subsequent risk of stroke, and guidelines on evaluation and treatment.
Similar content being viewed by others
References and Recommended Reading
Johnston SC: Transient ischemic attack. N Engl J Med 2002, 347:1687–1692.
Brainin M, McShane LM, Steiner M, et al.: Silent brain infarcts and transient ischemic attacks. A three-year study of first-ever ischemic stroke patients: the Klosterneuburg Stroke Data Bank. Stroke 1995, 26:1348–1352.
Johnston SC, Fayad P, Gorelick PB, et al.: Prevalence and knowledge of transient ischemic attacks among US adults. Neurology 2003, 60:1429–1434.
Fisher CM: Intermittent cerebral ischemia. In Cerebral Vascular Disease. Edited by Wright IS, Millikan CH. New York: Grune and Stratton; 1958:81–97.
Siekert RG, Whisnant JP. In Cerebral Vascular Diseases: Fourth Conference. New York: Grune and Stratton; 1965.
Kidwell CS, Alger JR, Di Salle F, et al.: Diffusion MRI in patients with transient ischemic attacks. Stroke 1999, 30:1174–1180.
Albers GW, Caplan LR, Easton JD, et al.: Transient ischemic attack—proposal for a new definition. N Engl J Med 2002, 347:1713–1716.
Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency-department diagnosis of transient ischemic attack. JAMA 2000, 284:2901–2906. This is the first large cohort to reveal the high early risk of stroke after a TIA.
Lovett JK, Dennis MS, Sandercock PA, et al.: Very early risk of stroke after a first transient ischemic attack. Stroke 2003, 34:138–140. This is the first population-based cohort to confirm the high early risk of stroke after a TIA.
Whisnant JP, Matsumoto N, Elveback LR: Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc 1973, 48:194–198.
Whisnant JP, Wiebers DO: Clinical epidemiology of transient cerebral ischemic attacks (TIA) in the anterior and posterior circulation. In Occlusive Cerebrovascular Disease. Edited by Sundt TM. Philadelphia: WB Saunders; 1987:60–65.
Coull AJ, Lovett JK, Rothwell PM: Population based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004, 328:326–328.
Streifler JY, Eliasziw M, Benavente OR, et al.: The risk of stroke in patients with first-ever retinal vs. hemispheric transient ischemic attacks and high-grade stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995, 52:246–249.
Gladstone DJ, Kapral MK, Fang J, et al.: Management and outcomes of transient ischemic attacks in Ontario. Can Med Assoc J 2004, 170:1099–1104.
Hill MD, Yiannakoulias N, Jeerakathil T, et al.: The high risk of stroke immediately after transient ischemic attack. Neurology 2004, 62:2015–2020.
Lisabeth LD, Ireland JK, Risser JM, et al.: Stroke risk after transient ischemic attack in a population-based setting. Stroke 2004, 35:1842–1846.
Kennedy J, Hill MD, Eliasziw M, et al.: Short-term prognosis following acute cerebral ischaemia. Stroke 2002, 33:382. This important analysis demonstrates that the risk of stroke after a TIA is significantly higher than the risk of stroke after a stroke.
Wiebers DO, Whisnant JP, O’Fallon WM: Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955–1974. Neurology 1982, 32:459–465.
Humphrey PR, Marshall J: Transient ischemic attacks and strokes with recovery prognosis and investigation. Stroke 1981, 12:765–769.
Johnston SC, Sidney S, Bernstein AL, Gress DR: A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA. Neurology 2003, 60:280–285.
Hankey GJ, Jamrozik K, Broadhurst RJ, et al.: Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998, 29:2491–2500.
Sacco RL, Shi T, Zamanillo MC, Kargman DE: Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994, 44:626–634.
Petty GW, Brown RD, Whisnant JP, et al.: Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998, 50:208–216.
Burn J, Dennis MS, Bamford JM, et al.: Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994, 25:333–337.
Johnston SC, Easton JD: Are patients with acutely recovered cerebral ischemia more unstable? Stroke 2003, 34:2446–2450. This article shows that early recovery, even if not complete, is likely a sign of instability and is associated with high risk of recurrence.
Johnston SC, Leira EC, Hansen MD, Adams HP: Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol 2003, 54:439–444. This study uses data from a randomized trial to show that patients with significant early recovery are actually at higher risk for subsequent ischemia.
Aslanyan S, Weir CJ, Johnston SC, Lees KR: Poststroke neurological improvement within 7 days is associated with subsequent deterioration. Stroke 2004, 35:2165–2170.
Alexandrov AV, Demchuk AM, Burgin WS, et al.: Ultrasoundenhanced thrombolysis for acute ischemic stroke: phase I. Findings of the CLOTBUST trial. J Neuroimaging 2004, 14:113–117.
Alexandrov AV, Felberg RA, Demchuk AM, et al.: Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 2000, 31:915–919.
Rordorf G, Cramer SC, Efird JT, et al.: Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety. Stroke 1997, 28:2133–2138.
Johnston CM, Sidney S, Gress DR, Johnston SC: The prognostic value of head computerized tomography in TIA evaluation. Neurology 2001, 56:A159-A160.
Gass A, Ay H, Szabo K, Koroshetz WJ: Diffusion-weighted MRI for the “small stuff”: the details of acute cerebral ischaemia. Lancet Neurol 2004, 3:39–45.
Elkins JS, Sidney S, Gress DR, et al.: Electrocardiographic findings predict short-term cardiac morbidity after transient ischemic attack. Arch Neurol 2002, 59:1437–1441.
Antithrombotic Trialists’ Collaboration: Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71–86.
Chen ZM, Sandercock PA, Pan HC, et al.: Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. Stroke 2000, 31:1240–1249.
Farrell B, Godwin J, Richards S, Warlow CP: The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991, 54:1044–1054.
The Dutch TIA Trial Group: A comparison of two doses of aspirin (30mg vs. 283mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991, 325:1261–1266.
Hankey GJ, Sudlow CL, Dunbabin DW: Thienopyridine dervatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev 2000, 2:CD001246.
CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329–1339.
Diener HC, Cunha L, Forbes C, et al.: European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996, 143:1–13.
Mohr JP, Thompson JL, Lazar RM, et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001, 345:1444–1451.
Gubitz G, Counsell C, Sandercock PA, Signorini D: Anticoagulants for acute ischaemic stroke. Cochrane Database Syst Rev 2000, 2:CD000024.
The North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991, 325:445–453.
The European Carotid Surgery Trialists’ Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998, 351:1379–1387.
Mayberg MR, Wilson SE, Yatsu F, et al.: Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991, 266:3289–3294.
Hebert PR, Gaziano JM, Chan KS, Hennekens CH: Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA 1997, 278:313–321.
Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebocontrolled trial. Lancet 2002, 360:7–22.
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358:1033–1041.
The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000, 342:145–153.
Dahlof B, Devereux RB, Kjeldsen SE: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995–1003.
Johnston SC, Smith W: Practice variability in management of transient ischemic attacks. Eur Neurol 1999, 42:105–108.
Nguyen-Huynh MN, Fayad P, Gorelick PB, Johnston SC: Knowledge and management of transient ischemic attacks among U.S. primary care physicians. Neurology 2003, 61:1455–1466.
Benade MM, Warlow CP: Cost of identifying patients for carotid endarterectomy. Stroke 2002, 33:435–439.
Berge E, Abdelnoor M, Nakstad PH, Sandset PM: Low molecularweight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. Lancet 2000, 355:1205–1210.
Saxena R, Lewis S, Berge E, et al.: Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001, 32:2333–2337.
Feinberg WM, Albers GW, Barnett HJ, et al.: Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Circulation 1994, 89:2905–2965.
Bruetman ME, Fields WS, Crawford ES, DeBakery ME: Cerebral hemorrhage in carotid artery surgery. Arch Neurol 1963, 9:458–467.
Wylie EJ, Hein MF, Adams JE: Intracranial hemorrhage following surgical revascularization for treatment of acute strokes. J Neurosurg 1964, 21:212–215.
Rothwell PM, Eliasziw M, Gutnikov SA, et al.: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004, 363:915–924. The results of this analysis showed that the greatest benefit of endarterectomy was seen with earlier randomization for surgery, and argued for the use of carotid endarterectomy early after TIA.
Johnston SC, Nguyen-Huynh MN: Is hospitalization after TIA cost-effective simply on the basis of treatment with tPA? Paper presented at American Heart Association 29th International Stroke Meeting, San Diego, CA, 2004.
Putman SF, Adams HP: Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol 1985, 42:960–962.
Biller J, Bruno A, Adams HP: A randomised trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Stroke 1989, 20:441–447.
Panagos PD, Pancioli AM, Khoury J, et al.: Short-term prognosis after emergency department diagnosis and evaluation of transient ischemic attack (TIA). Acad Emerg Med 2003, 10:432b-433b.
Mielke O, Pullwitt A, Hennerici M, et al.: Transient ischemic attacks are more than “mini-strokes”. Stroke 2004, 35:245.
Albers GW, Hart RG, Lutsep HL, et al.: Supplement to the guidelines for the management of transient ischemic attacks. A statement from the ad hoc committee on guidelines for the management of transient ischemic attacks, stroke council, American Heart Association. Stroke 1999, 30:2502–2511.
National Stroke Association: Stroke Prevention Guidelines [online]. Available at: http://www.stroke.org/. Accessed August 17, 2004.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nguyen-Huynh, M.N., Johnston, S.C. Transient ischemic attack: A neurologic emergency. Curr Neurol Neurosci Rep 5, 13–20 (2005). https://doi.org/10.1007/s11910-005-0018-z
Issue Date:
DOI: https://doi.org/10.1007/s11910-005-0018-z